Revisions for Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. | Registro Público Cubano de Ensayos Clínicos

The revisions let you track differences between multiple versions of a post.

To edit, publish or delete one of the revisions below, click on its saved date.

Published clinical_trials Exploratory, open and multicenter study of the use of the humanized monoclonal antibody itolizumab (antiCD6) in patients with solid tumors. has 2 revisions.

Revision		Status
Saved 19/12/2025 - 2:24pm by Gladys		current revision (published)
Saved 18/06/2024 - 10:15am by Gladys Numero de Registro de Autorizacion de uso de emergencia ; AUE 02/2020 23.021.20B		archived

Registered Trials

Registration process

About the RPCEC

Useful resources